| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/24/2000 | WO2000009119A1 Hydroxamic acid derivatives as inhibitors of beta-amyloid production |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009103A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009080A1 Incorporation of exogenous lactic bacteria into the oral microflora |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | WO2000009070A2 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | WO2000002905A3 Methods for accelerating bone and cartilage growth and repair |
| 02/24/2000 | WO2000002579A3 Component b as angiogenic agent in combination with human growth factors |
| 02/24/2000 | WO2000000039B1 Process and product for promoting weight loss in overweight dogs |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999064421B1 Acetylcholine enhancers |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999058098A8 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 02/24/2000 | WO1999057133A3 Inhibitors of nf-kb activation |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837387A1 New nucleic acid analogs useful in therapeutic or diagnostic agents or electronic components, consist of 3'-deoxypentopyranosyl nucleosides |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | DE19828624C1 Modular aufgebaute RNA-Moleküle mit zwei Sequenzbereichstypen Modular RNA molecules with two types of sequence region |
| 02/24/2000 | CA2341029A1 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340668A1 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340176A1 Inhibition of pathogenic processes related to tissue trauma |
| 02/24/2000 | CA2340167A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | CA2339562A1 1h-imidazopyridine derivatives |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338386A1 Proteases and associated proteins |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336147A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980864A2 Sulphonamide derivatives |
| 02/23/2000 | EP0980437A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980432A1 Chimeric opg polypeptides |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980381A1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| 02/23/2000 | EP0980379A2 Chimeric oligonucleotides and the use thereof |
| 02/23/2000 | EP0980374A1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/23/2000 | EP0980373A1 Reverse-turn mimetics and methods relating thereto |
| 02/23/2000 | EP0980371A1 Tricyclic pyridone analogues as gaba-a receptor ligands |
| 02/23/2000 | EP0980370A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 02/23/2000 | EP0980368A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980367A1 Antithrombotic agents |
| 02/23/2000 | EP0980366A1 Antithrombotic agents |
| 02/23/2000 | EP0980362A1 Substituted heterocycles and their use in medicaments |
| 02/23/2000 | EP0980358A1 Pharmacological agents |
| 02/23/2000 | EP0980357A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
| 02/23/2000 | EP0980252A1 Therapies for acute renal failure |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980244A1 Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 02/23/2000 | EP0980241A1 Gelatine encapsulated solution dosage forms of sertraline |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |
| 02/23/2000 | EP0861226B1 Synthesis of carboxylic acid derivatives |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | EP0775138B1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
| 02/23/2000 | CN1245495A N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 02/23/2000 | CN1245493A Asymmetric synthesis of benzoxazinones |
| 02/23/2000 | CN1245491A 5-cyclo indole compounds as 5-HT receptor ligands |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245434A Stable liquid interferon formulations |
| 02/23/2000 | CN1245425A Poly(diallylamine)-based bile acid sequestrants |
| 02/23/2000 | CN1245169A Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 02/23/2000 | CN1245066A Composite tea of wild nine-leaf gynostemma pentaphyllum |
| 02/23/2000 | CN1049660C Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028207 A tetracycline type antibiotic covalent bonded with a steroid type hormone estrogen has an osteogenesis function in addition to a bone resorption inhibition, can concentrate on the bone tissues |
| 02/22/2000 | US6028197 Dibenzo[a,g]quinolizinium derivatives and the salts thereof |
| 02/22/2000 | US6028171 Class I MHC modulation of surface receptor activity |
| 02/22/2000 | US6028114 Use of aminothiolester derivatives in pharmaceutics |
| 02/22/2000 | US6028111 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 02/22/2000 | US6028110 Succinyl hydroxamic acid, N-formyl-N-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 02/22/2000 | US6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
| 02/22/2000 | US6028090 Adhesion receptor antagonists III |
| 02/22/2000 | US6028086 Selective inhibitors of phosphodiesterase (pde) type iv or production of tumor necrosis factor (tnf) and as such are useful treatment of asthma, arthritis, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis |
| 02/22/2000 | US6028084 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 02/22/2000 | US6028082 For trating psychological disorders |
| 02/22/2000 | US6028075 Administering pharmaceutically effective amount of a compound for treatment of tumor sensitive to the compound |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6028073 For treating psychoses |